Year archive

Hutchmed (China) Limited — 2016 filings

All 81 regulatory filings released by Hutchmed (China) Limited (HCM) in 2016, sourced directly from the official regulator.

81 Filings

2016 Period

2016 filings (81)

Filing	Released	Lang
6-K Regulatory Filings	2016-12-30	English
Total Voting Rights Regulatory Filings	2016-12-30	English
6-K Regulatory Filings	2016-12-29	English
Blocklisting Six Monthly Return Regulatory Filings	2016-12-29	English
6-K Regulatory Filings	2016-12-20	English
Director's Share Dealing Director's Dealing	2016-12-20	English
6-K Regulatory Filings	2016-12-14	English
Director's Share Dealing Director's Dealing	2016-12-14	English
6-K Regulatory Filings	2016-12-06	English
6-K Regulatory Filings	2016-11-30	English
Exercise of Share Options Director's Dealing	2016-11-30	English
Total Voting Rights Regulatory Filings	2016-11-30	English
6-K Regulatory Filings	2016-11-23	English
Director's Share Dealing Director's Dealing	2016-11-23	English
6-K Regulatory Filings	2016-11-14	English
6-K Regulatory Filings	2016-11-01	English
Director's Share Dealing Director's Dealing	2016-11-01	English
6-K Regulatory Filings	2016-10-31	English
Joint Venture - US$59.5m Land Compensation Payment Regulatory Filings	2016-10-31	English
6-K Regulatory Filings	2016-10-12	English
Director's Share Dealing Director's Dealing	2016-10-12	English
6-K Regulatory Filings	2016-08-09	English
Director's Share Dealing Director's Dealing	2016-08-09	English
6-K Regulatory Filings	2016-08-02	English
Change of Non-executive Directors Board/Management Information	2016-08-02	English
Chi-Med 2016 Interim Results Earnings Release H1 2016	2016-08-02	English
6-K Regulatory Filings	2016-08-01	English
Chi-Med and AstraZeneca to Accelerate Savolitinib Regulatory Filings	2016-08-01	English
6-K Regulatory Filings	2016-07-06	English
S-8 Regulatory Filings	2016-07-06	English
Chi-Med to Announce 2016 HY Financial Results Report Publication Announcement	2016-07-05	English
6-K Regulatory Filings	2016-06-30	English
Blocklisting Six Monthly Return Regulatory Filings	2016-06-29	English
6-K Regulatory Filings	2016-06-21	English
Savolitinib Global Phase II Trial Initiated Regulatory Filings	2016-06-20	English
6-K Regulatory Filings	2016-06-16	English
6-K Regulatory Filings	2016-06-01	English
Total Voting Rights Regulatory Filings	2016-05-31	English
6-K Regulatory Filings	2016-05-16	English
Enrollment completion of Phase III fruquintinib Regulatory Filings	2016-05-13	English
6-K Regulatory Filings	2016-04-29	English
Total Voting Rights Regulatory Filings	2016-04-29	English
6-K Regulatory Filings	2016-04-28	English
Results of Annual General Meeting Declaration of Voting Results & Voting Rights Announcements	2016-04-27	English
6-K Regulatory Filings	2016-04-14	English
Exercise of Overallotment Option Regulatory Filings	2016-04-13	English
6-K Regulatory Filings	2016-04-13	English
Clinical trial of novel PI3K inhibitor HMPL-689 Regulatory Filings	2016-04-12	English
Total Voting Rights Regulatory Filings	2016-03-31	English
6-K Regulatory Filings	2016-03-30	English
Director/PDMR Shareholding Director's Dealing	2016-03-29	English
6-K Regulatory Filings	2016-03-24	English
Holding(s) in Company Major Shareholding Notification	2016-03-23	English
Closing of U.S. Public Offering of ADSs Capital/Financing Update	2016-03-22	English
6-K Regulatory Filings	2016-03-22	English
Regulatory Filings 2016 Regulatory Filings	2016-03-21	English
Director/PDMR Shareholding Director's Dealing	2016-03-21	English
Sulfatinib Phase III registration study Regulatory Filings	2016-03-21	English
Regulatory Filings 2016 Regulatory Filings	2016-03-21	English
Final Prospectus Capital/Financing Update	2016-03-18	English
424B4 Regulatory Filings	2016-03-18	English
Pricing of U.S. Public Offering of ADSs Capital/Financing Update	2016-03-17	English
Regulatory Filings 2016 Regulatory Filings	2016-03-17	English
F-1MEF Regulatory Filings	2016-03-17	English
AUTO-GENERATED PAPER DOCUMENT Regulatory Filings	2016-03-16	English
Regulatory Filings 2016 Regulatory Filings	2016-03-16	English
Regulatory Filings 2016 Regulatory Filings	2016-03-16	English
2015 Annual Report and Notice of AGM Report Publication Announcement	2016-03-15	English
Fifth Filing of Form F-1 Registration Statement Regulatory Filings	2016-03-07	English
REGISTRATION STATEMENT Regulatory Filings	2016-03-04	English
8-A12B Regulatory Filings	2016-03-04	English
Fifth Filing of Form F-1 Registration Statement Regulatory Filings	2016-03-04	English
F-1/A Regulatory Filings	2016-03-04	English
Sulfatinib Phase II initation in thyroid cancer Regulatory Filings	2016-03-02	English
Fourth Filing of Form F-1 Registration Statement Regulatory Filings	2016-03-01	English
F-1/A Regulatory Filings	2016-03-01	English
Final Results Earnings Release FY 2015	2016-03-01	English
Public Filing of Form F-1 Registration Statement Capital/Financing Update	2016-02-11	English
F-1/A Regulatory Filings	2016-02-11	English
Notice of Results Report Publication Announcement	2016-01-29	English
Chi-Med initiates HMPL-523 Phase I clinical trial Regulatory Filings	2016-01-15	English

Filings by year

2026 30 filings
2025 104 filings
2024 105 filings
2023 108 filings
2022 96 filings
2021 149 filings
2020 122 filings
2019 71 filings
2018 77 filings
2017 88 filings
2016 81 filings
2015 53 filings
2014 28 filings
2013 23 filings